EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Involvement of the Endocannabinoid, Glutamatergic, and GABAergic Systems in PTSD

Anna Dorota Grzesińska iD

International Journal of Molecular Sciences · 20.06.2025 · 26 (13) · 5929

DOI: 10.3390/ijms26135929 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.06.2025. Verfasst von Anna Dorota Grzesińska. Beteiligte Einrichtung: Collegium Medicum, Jan Dlugosz University in Czestochowa, ul. Waszyngtona 4/8, 42-200 Częstochowa, Poland. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, Endocannabinoids, Glutamic Acid, gamma-Aminobutyric Acid. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Centre for Research and Development, National Center for Research and Development, ERA-Net Neuron.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-traumatic stress disorder (PTSD) is a debilitating mental health condition that develops in response to traumatic events. The endocannabinoid, glutamatergic, and GABAergic systems play crucial roles in the neurobiological mechanisms of PTSD. Both the endocannabinoid, glutamatergic, and GABAergic systems are involved in synaptic remodeling and neuronal differentiation, ensuring efficient information transmission in the brain. Their interplay influences motivation, behavior, sensory perception, pain regulation, and visual processing. Additionally, these systems regulate processes such as cellular proliferation, adhesion, apoptosis, and immune responses. This article explores the involvement of the endocannabinoid, glutamatergic, and GABAergic systems in PTSD pathogenesis. A literature review was conducted on studies examining the relationship between the endocannabinoid, glutamatergic, and GABAergic systems in PTSD. Relevant publications were sourced from the Web of Science and Scopus databases, covering research up to 29 February 2025. Neurobiological mechanisms underlying PTSD may share common pathways with other mental and somatic disorders, particularly those involving inflammatory processes. The identification of biomarkers is crucial for assessing PTSD risk and implementing targeted interventions to improve patient outcomes. A deeper understanding of these mechanisms could enhance therapeutic strategies, ultimately improving the quality of life for individuals affected by PTSD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stress Disorders, Post-TraumaticEndocannabinoidsGlutamic Acidgamma-Aminobutyric AcidHumansAnimalsBrain

Stichwörter der Autor:innen

GABAergic systemendocannabinoid systemglutamatergic systempost-traumatic stress disorder

Substanzen

EndocannabinoidsGlutamic Acidgamma-Aminobutyric Acid

Autor:innen und Institutionen

  • Collegium Medicum, Jan Dlugosz University in Czestochowa, ul. Waszyngtona 4/8, 42-200 Częstochowa, Poland.

ORCID-Profile: Anna Dorota Grzesińska

Förderung

  • National Centre for Research and Development
  • National Center for Research and Development
  • ERA-Net Neuron

Zitieren

APA

Grzesińska, A. D. (2025). The Involvement of the Endocannabinoid, Glutamatergic, and GABAergic Systems in PTSD. International Journal of Molecular Sciences, 26(13), 5929. https://doi.org/10.3390/ijms26135929

Vancouver

Grzesińska AD. The Involvement of the Endocannabinoid, Glutamatergic, and GABAergic Systems in PTSD. International Journal of Molecular Sciences. 2025;26(13):5929. doi:10.3390/ijms26135929

BibTeX
@article{Grzesiska2025,
  author = {Grzesińska, Anna Dorota},
  title = {The Involvement of the Endocannabinoid, Glutamatergic, and GABAergic Systems in PTSD},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {13},
  pages = {5929},
  doi = {10.3390/ijms26135929}
}
Kostenlos starten →